David Mountcastle, serving as Executive Vice President and Chief Financial Officer for Privia Health Group, Inc. (NASDAQ:PRVA), completed a divestment of 600 shares of the company's common stock on July 7, 2026. The total value realized from this transaction was recorded at $16,542. The shares were liquidated at prices fluctuating between $27.55 and $27.58 per share, resulting in a weighted average sale price of $27.57. This execution was conducted under the parameters of a Rule 10b5-1 trading plan, a mechanism that permits insiders to establish a fixed schedule for buying or selling company equity in advance.
Following the completion of this sale, Mountcastle's direct ownership stake in Privia Health Group stands at 186,128 shares. Furthermore, an additional 8,695 shares are maintained indirectly through his spouse. The timing of this insider transaction coincides with PRVA trading at $27.77, a level closely aligned with its 52-week high of $27.70. Over the preceding year, the stock has generated returns of 28%. According to analysis from InvestingPro, the current valuation suggests the stock may be slightly undervalued. Market analysts maintain a bullish stance on the healthcare company, with price targets established between $24 and $40.
Recent corporate developments provide additional context for investors. Privia Health Group reported its first-quarter 2026 earnings, revealing a mixed financial performance. The company missed earnings per share expectations, posting an EPS of $0.02 against a forecast of $0.0746, marking a 73.19% shortfall. Conversely, revenue surpassed projections, achieving $603.85 million compared to the expected $559.49 million, representing a 7.93% positive surprise. Additionally, shareholders approved all proposals at the 2026 Annual Meeting of Stockholders. This approval included the election of three Class I directors: Nancy Cocozza, David King, and Francis Soistman, who will serve until the 2029 Annual Meeting. These events underscore significant financial and governance dynamics for stakeholders to evaluate.